Moelis ( (MC) ) just unveiled an update.
Moelis & Company reported a slight increase in third-quarter adjusted revenues to $280.7 million, amid a notable rise in net income, signaling growth from the previous year despite market volatility. The firm achieved a significant 18% increase in adjusted revenues over the first nine months of 2024, reflecting its strategic expansion and strong financial position with a cash reserve of $297.7 million. Investors might find the consistent quarterly dividend of $0.60 per share appealing as Moelis continues to bolster its leadership and expertise, particularly in the biotech sector.
For detailed information about MC stock, go to TipRanks’ Stock Analysis page.
